Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 1001 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Woman Diagnosed with Cancer a Week After Her Honeymoon Helps Others... June 2, 2021 How Can Hormone Replacement Therapy for Menopause Impact My Cancer Risk? January 4, 2023 FDA Approves BCMA-Targeted CAR T-Cell Therapy for Multiple Myeloma April 14, 2021 EMA Recommends Extension of Therapeutic Indications for Ibrutinib July 15, 2022 Load more HOT NEWS President’s Cancer Panel Report: Closing Gaps in Cancer Screening for All... Nanoparticle Trains Immune Cells to Attack Cancer Worries About Medical Bills May Worsen Health Outcomes After Cancer Diagnosis More Immunotherapy Options Approved for Treating Endometrial Cancer
